Firms occupied with maintaining our health and well-being have been spotlighted frequently in this column, as they have been uppermost in small-cap investors’ minds for some time.
The health-care sector needed a bit of coaxing in the U.S., losing 0.7% by Tuesday’s last hour of trade, while in Canada, the sector slid 1.8%.
Even so, two such companies managed to shine.
Los Angeles-based Full Alliance Group, Inc. (OTC:FAGI) saw its shares reaching for the heavens Tuesday on the release of its Shareholder Update
CEO Brian Volpp told shareholders, “We in the medical community are hopeful that an effective vaccine will be developed soon that will protect our populations.”
In the meantime, Volpp emphasized, “given the lack of durable immune protection it appears that a reasonable approach to treating a virus such as COVID-19 would be to do everything that can be done to support the body's own immunity, so that the virus can be eliminated or at least controlled endogenously and symptoms minimized.”
Full Alliance is a diverse public holding company that acquires assets in the Healthcare, Nutraceutical and Cardiovascular healing space.
FAGI shares ballooned 35.3% to 2.3 cents, on 290,000 shares.
North of the border, Moncton, New Brunswick-based Organigram Holdings Inc. (TSX:OGI) entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd. a subsidiary of InterCure Ltd.
Under the agreement, OGI will provide a guaranteed 3,000 kg of high quality, indoor-grown dried flower product to Canndoc by the end of next year for processing and distribution into the Israeli medical market, and may provide an additional 3,000 kg during the same time period at Canndoc’s option, subject to certain conditions.
OGI shares climbed 12 cents, or 4.4%, to $2.83, on a volume of 2.9 million shares.
